Executive Board Member @ (February 2019 - November 2020)
Member Of The Board Of Advisors @ (November 2021 - July 2026)
Member, Editorial Board @ Lattice - Machine Learning Peer Reviewed Journal, Association of Data Scientists (June 2020 - July 2025)
Chief AI Officer @ (October 2018 - November 2020)
GLOBAL HEAD ARTIFICIAL INTELLIGENCE and DATA SCIENCE and Head-Artificial Intelligence Learning Institute @ (January 2016 - September 2018)
Head of Data Science @ (January 2016 - January 2018)
Chief Data Scientist and Managing Partner @ MacLaughlin Global Innovations & Investments (January 2014 - January 2016)
National Director, Collections Operations, Analytics and Performance Evaluation @ (September 2011 - January 2016)
Senior Director, Collections Operations @ (May 2013 - May 2015)
Adjunct Research Fellow @ (August 2008 - October 2014)
Manager: Donor Services Quality Assurance, Education and Donor Records @ Rhode Island Blood Center (May 2010 - September 2011)
Principal @ MacLaughlin Executive Research (January 2008 - July 2010)
Chief Data Scientist and Managing Director @ Browning Associates (August 2007 - August 2009)
Founder @ MacLaughlin Global Holdings (August 2002 - August 2008)
Periconceptional Group Leader (Lecturer) @ (January 2006 - January 2008)
Postgraduate Scholar @ (January 2001 - January 2006)
Chairman @ SA Branch Australian Society for Medical Research (January 2002 - January 2004)
Severence MacLaughlin Education
University of Adelaide
Ph.D (Embryonic and Fetal Development)
2001-2006
Cornell University
Bachelor of Science (Animal Sciences)
1996-2000
Bishop Hendricken 1992-1996
Texas A&M University
University Of Adelaide, South Australia, Australia
Doctor of Philosophy
Severence MacLaughlin Skills
AI Policy, Governance, and Regulation
AI for Finance
AI for Financial Forecasting
Agentic AI Development
Analysis
Analytics
Animal Science
Artificial Intelligence (AI)
Artificial Intelligence Foundations
Artificial Intelligence Management System (AIMS)
Artificial Neural Networks
Big Data
Biochemistry
Biopharmaceuticals
Biotechnology
Blood Bank
Blood Collection
Blood Transfusion
Budgets
Business Development
Business Planning
Business Strategy
CPG Industry
CPG Supply chain
Clinical Development
Clinical Trials
Competitive Intelligence
Computer Vision
Consulting
Consumer Packaged Goods (CPG)
Contract Negotiation
DNA
Data Analysis
Data Engineering
Data Science
Data Visualization
Drug Development
Drug Discovery
Due Diligence
Embryology
Entrepreneurship
FDA
FDA GMP
Finance
Financial Instruments
Financial Research
Fundraising
Generative AI for Supply Chains
Generative for healthcare
Healthcare
Histology
Immunology
In Vitro Fertilization (IVF)
Large Language Models (LLM)
Leadership
Lifesciences
Machine Learning
Management
Management Consulting
Market Research
Marketing
Medical Devices
Medical Education
Medical Science
Mergers
Mergers & Acquisitions
Molecular Biology
Nonprofits
Oncology
Operational Efficiency
Pharmaceutical Industry
Placenta Encapsulation
Predictive AI
Predictive Analytics
Predictive Maintenance
Pregnancy
Product Development
Productivity Improvement
Protein Expression
Python (Programming Language)
Qualitative Research
Quality Assurance
RNA
Real World Data (RWD)
Real World Evidence (RWE)
Recruiting
Regulatory Compliance
Research
Research and Development (R&D)
Science
Start-ups
Statistics
Strategic Analytics
Strategic Planning
Strategy
Talent Acquisition
Teaching
Technology Transfer
Training
Venture Capital
In Vivo
Texas
USDA
Conferences
FMLA
Responsibility
Utilization
Engineering
Pqm
Efficiencies
Profit
Project Leadership
Human Services
Founding
International
Economy
Information Technology
Students
Scholarships
Public Relations
Thesis
Scientific
Assessment
Connecticut
Change Management
Six Sigma
Data Models
American
Networking
Reproductive Biology
Australian
Data Integrity
Savings
Congress
Politicians
Project Management
Institutional Investments
High School Students
Polo
Council
Manufacturing
Red Cross
Foundation
Raising
Media Exposure
Mergers and Acquisitions
Ex Vivo
Big Data Analytics
Investigation
Policy Development
New York
Health Research
Information Management
Medical Research
Fortune 500
Disease
Communication
Prototype
Field Operations
Australia
Programming
Molecular
Information Systems
Data Warehousing
Scientific Presentation
Deployed
Doh
Media Relations
Telecommunications
Technology
Apheresis
Technology Solutions
Tableau
Christian Ministry
Pharmaceutics
Reproductive
Windows Vista
Plot
Keynote Speaker
Philosophy
Settlement
Sponsorship
Project
System
International Travel
Channel
Strike
Business Intelligence
Supply
Print
Television
SPSS
Blood
Clinical Research
Operations
Stewardship
Entertainment
Physiology
OSHA
Educational Outreach
Investments
Academic
Start Ups
Auditing
Solutions
Cost Savings
Publications
Spokesperson
Radio
Coordinated
Trade Unions
Travel
Developmental
Severence MacLaughlin Summary
Severence MacLaughlin, based in New York, NY, US, is currently a Chief AI Officer at WellStack. Severence MacLaughlin brings experience from previous roles at Seraph Artificial Intelligence, DeLorean Artificial Intelligence and Otter Waiver. Severence MacLaughlin holds a 2001 - 2006 Ph.D in Embryonic and Fetal Development @ University of Adelaide. With a robust skill set that includes AI Policy, Governance, and Regulation, AI for Finance, AI for Financial Forecasting, Agentic AI Development, Analysis and more. Severence MacLaughlin has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Severence MacLaughlin?
Find contact details for 700 million professionals.